SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AVANT Immunotherapeutics Inc. (Nasdaq: AVAN)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
513 25 0 AVAN
Emcee:  Harry Stover Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
413AVANT Completes Enrollment in CETi-1 Phase II Study NEEDHAM, Mass.--(BW HealthWSemiBull-8/1/2002
412AVANT Immunotherapeutics Reports Second Quarter 2002 Financial Results NEEDHAM, SemiBull-7/24/2002
411AVANT Immunotherapeutics Awarded SBIR Grant to Develop Anthrax Vaccine NEEDHAM,SemiBull-7/2/2002
410Investors Invited to Hear From Biotechnology firm AVANT Immunotherapeutics at thSemiBull-6/26/2002
409Avant Immunotherapeutics Receives Key Patent for Its Cholesterol Management VacPatricia Meaney-6/25/2002
408Queen of England Honors AVANT Immunotherapeutics CEO, Una S. Ryan, With OBE NEESemiBull-6/17/2002
407An Open Letter to the Biotech Industry... It's pretty clear that the SThe Fox-6/16/2002
406Safety, workload cited for perceived FDA backlog By Deena Beasley TORONTO, JuSemiBull-6/11/2002
405AVANT Commences Second Phase II Study of Its Cholera Vaccine NEEDHAM, Mass.--(BSemiBull-5/16/2002
404AVANT Immunotherapeutics Reports First Quarter 2002 Financial Results NEEDHAM, SemiBull-4/24/2002
403No message. EOM.keokalani'nui-4/18/2002
402AVANT to Present At Bio-defense Conference NEEDHAM, Mass.--(BW HealthWire)--AprSemiBull-4/17/2002
401Interesting post from Yahoo board. At 10:30 AM, a big time inflection took aknahow-4/11/2002
400Six months have gone by, so the booster shots have been administered. Not sure aknahow-4/11/2002
399Roger, I like the endpoint. The principal endpoint is the change in HDL cholesaknahow-3/31/2002
398Thanks, speed reading is not that great if you miss the main point as I did. Waaknahow-3/30/2002
397They were not mentioned in the Nightline article. The older article does mentioaknahow-3/30/2002
396AVAN is mentioned... <In response to poor patient compliance and cholesterolRoger Bodine-3/30/2002
395YES! YES! It is about AVAN. Previous info shows same doctor and same Rush invaknahow-3/30/2002
394Apparently was nightline and i missed it. more.abcnews.go.com AVAN is not mentaknahow-3/30/2002
393Next week Friday ABC's, 20/20 will have a segment on "Can a vaccine loaknahow-3/23/2002
392I guess there was a little over-reaction, but not that much. I hope they come o613-2/27/2002
391AVANT Reports Fourth Quarter and Fiscal 2001 Financial Results Provides 2002 FiSemiBull-2/26/2002
390Love in the Time of Cholera By Matthew Goldstein Avant Immunotherapeutics Inc.SemiBull-2/22/2002
389AVANT Signs Cholera Vaccine Agreement With International Vaccine Institute NEEDSemiBull-2/21/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News